Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mauro Zaffaroni

Showing results (1-10 of 92) with videos related to

Pageof 10
Sort By:
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|May 4, 2021
Fingolimod in pediatric-onset multiple sclerosisMauro Zaffaroni
Expert Review of Neurotherapeutics|May 29, 2008
Female-specific issues in multiple sclerosisAngelo Ghezzi, Mauro Zaffaroni
The Journal of Pediatrics|April 25, 2003
Back to sleep: risk factors for SIDS as targets for public health campaignsGuido Pastore, Andrea Guala, Mauro Zaffaroni
Journal of Neuroimmunology|December 4, 2014
Levels of mRNA for dopaminergic receptor D₅ in circulating lymphocytes may be associated with subsequent response to interferon-β in patients with multiple sclerosisMarco Cosentino, Mauro Zaffaroni, Franca Marino
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|April 14, 2022
Cost-utility analysis of teriflunomide in naïve vs. previously treated patients with relapsing-remitting multiple sclerosis in ItalyCarlo Lazzaro, Roberto Bergamaschi, Mauro Zaffaroni, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|July 22, 2017
Hypomagnesaemia as a trigger of relapsing non-alcoholic Wernicke encephalopathy: a case reportDamiano Baroncini, Pietro Annovazzi, Giorgio Minonzio, et al.
Health Economics Review|January 21, 2025
Matters arising: cost-utility and cost-effectiveness analysis of disease-modifying drugs of relapsing-remitting multiple sclerosis: a systematic reviewCarlo Lazzaro, Roberto Bergamaschi, Mauro Zaffaroni, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|October 4, 2008
Induction and add-on therapy with mitoxantrone and interferon beta in multiple sclerosisMauro Zaffaroni, Annalisa Rizzo, Silvana Maria Baldini, et al.
BMC Pediatrics|December 7, 2005
The impact of national and international guidelines on newborn care in the nurseries of Piedmont and Aosta Valley, ItalyAndrea Guala, Roberta Guarino, Mauro Zaffaroni, et al.
Journal of the Neurological Sciences|July 28, 2014
Uhthoff's phenomena and brain MRI suggesting demyelinating lesions: RIS or CIS? A case reportDamiano Baroncini, Mauro Zaffaroni, Giorgio Minonzio, et al.
Pageof 10

Showing results (1-10 of 92) with videos related to

Sort By:
Pageof 10
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|May 4, 2021
Fingolimod in pediatric-onset multiple sclerosisMauro Zaffaroni
Expert Review of Neurotherapeutics|May 29, 2008
Female-specific issues in multiple sclerosisAngelo Ghezzi, Mauro Zaffaroni
The Journal of Pediatrics|April 25, 2003
Back to sleep: risk factors for SIDS as targets for public health campaignsGuido Pastore, Andrea Guala, Mauro Zaffaroni
Journal of Neuroimmunology|December 4, 2014
Levels of mRNA for dopaminergic receptor D₅ in circulating lymphocytes may be associated with subsequent response to interferon-β in patients with multiple sclerosisMarco Cosentino, Mauro Zaffaroni, Franca Marino
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|April 14, 2022
Cost-utility analysis of teriflunomide in naïve vs. previously treated patients with relapsing-remitting multiple sclerosis in ItalyCarlo Lazzaro, Roberto Bergamaschi, Mauro Zaffaroni, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|July 22, 2017
Hypomagnesaemia as a trigger of relapsing non-alcoholic Wernicke encephalopathy: a case reportDamiano Baroncini, Pietro Annovazzi, Giorgio Minonzio, et al.
Health Economics Review|January 21, 2025
Matters arising: cost-utility and cost-effectiveness analysis of disease-modifying drugs of relapsing-remitting multiple sclerosis: a systematic reviewCarlo Lazzaro, Roberto Bergamaschi, Mauro Zaffaroni, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|October 4, 2008
Induction and add-on therapy with mitoxantrone and interferon beta in multiple sclerosisMauro Zaffaroni, Annalisa Rizzo, Silvana Maria Baldini, et al.
BMC Pediatrics|December 7, 2005
The impact of national and international guidelines on newborn care in the nurseries of Piedmont and Aosta Valley, ItalyAndrea Guala, Roberta Guarino, Mauro Zaffaroni, et al.
Journal of the Neurological Sciences|July 28, 2014
Uhthoff's phenomena and brain MRI suggesting demyelinating lesions: RIS or CIS? A case reportDamiano Baroncini, Mauro Zaffaroni, Giorgio Minonzio, et al.
Pageof 10